Quantum Biopharma (QNTM) Intangibles (2019 - 2026)

Quantum Biopharma (QNTM) has 8 years of Intangibles data on file, last reported at $4.4 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 8.71% year-over-year to $4.4 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (down 8.71% YoY), and the FY2025 full-year result was $4.5 million, down 8.53% from the prior year.
• Intangibles declined to $4.4 million in Q1 2026, from $4.5 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $15.4 million in Q1 2022 to a low of $4.4 million in Q1 2026.
• A 5-year average of $7.6 million and a median of $5.1 million in 2024 frame the typical range for Intangibles.
• Across the five-year window, Intangibles gained 19.01% in 2022 and sank 60.98% in 2023, its largest moves.
• Tracing QNTM's Intangibles over 5 years: stood at $12.0 million in 2022, then tumbled by 54.64% to $5.5 million in 2023, then decreased by 9.66% to $4.9 million in 2024, then dropped by 8.53% to $4.5 million in 2025, then slipped by 2.3% to $4.4 million in 2026.
• Business Quant data shows QNTM's Intangibles at $4.4 million in Q1 2026, $4.5 million in Q4 2025, and $4.6 million in Q3 2025.